Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-5-2
pubmed:abstractText
Gonadotropin-producing pituitary adenomas are extremely rare in reproductive-age women. We report here a case of gonadotroph microadenoma with ovarian hyperstimulation. It was found in a 29-yr-old infertile Japanese woman with enlarged multicystic ovaries. The patient had an elevated basal serum estradiol level (up to 6755 pM, or 1840 pg/ml). Serum FSH and prolactin were mildly elevated (15.4 IU/liter, 1.4 nM or 31.4 ng/ml), whereas LH was low (0.5 IU/liter). The FSH level was paradoxically elevated in response to TRH administration. Dynamic magnetic resonance imaging revealed a pituitary microadenoma. Daily administration of bromocriptine, a dopamine agonist, normalized the ovarian size, and the patient ovulated naturally. She conceived after 3 months of bromocriptine therapy and delivered a normal child. She underwent elective transsphenoidal pituitary surgery, 3 yr after the delivery. Immunostaining of the resected tumor showed that 80% and less than 5% of the tumor cells stained for FSH-beta and prolactin, respectively. Furthermore, RT-PCR suggested that dopamine type 2 receptor was expressed in the adenoma. Gonadotroph microadenoma should be considered in women with spontaneous ovarian hyperstimulation, even if they have no neurological symptoms or marked pituitary enlargement. In such cases, bromocriptine therapy may be an alternative to pituitary surgery.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-972X
pubmed:author
pubmed:issnType
Print
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1988-93
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12727942-Adenoma, pubmed-meshheading:12727942-Adult, pubmed-meshheading:12727942-Anovulation, pubmed-meshheading:12727942-Bromocriptine, pubmed-meshheading:12727942-Estradiol, pubmed-meshheading:12727942-Female, pubmed-meshheading:12727942-Follicle Stimulating Hormone, pubmed-meshheading:12727942-Follicle Stimulating Hormone, beta Subunit, pubmed-meshheading:12727942-Humans, pubmed-meshheading:12727942-Infertility, Female, pubmed-meshheading:12727942-Magnetic Resonance Imaging, pubmed-meshheading:12727942-Ovarian Hyperstimulation Syndrome, pubmed-meshheading:12727942-Pituitary Neoplasms, pubmed-meshheading:12727942-Pregnancy, pubmed-meshheading:12727942-Prolactin, pubmed-meshheading:12727942-RNA, Messenger, pubmed-meshheading:12727942-Receptors, Dopamine D2, pubmed-meshheading:12727942-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:12727942-Tomography, X-Ray Computed
pubmed:year
2003
pubmed:articleTitle
Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
pubmed:affiliation
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't